Report Detail
Global Drug Device Combination Products Market Professional Survey Report 2019
- RnM3733443 |
- 07 September, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
Drug devices facilitate early diagnosis and reduced treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.
The global drug device combination product market size is expected to reach USD 176 billion by 2024. Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.
Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.
The global Drug Device Combination Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug Device Combination Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Device Combination Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drug Device Combination Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drug Device Combination Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Terumo Corporation
Stryker Corporation
Mylan N.V.
Medtronic
St.Jude Medical, Inc.
Allergan, Plc
Boston Scientific Corporation
Novartis AG
Teleflex Incorporated
C.R. Bard, Inc.
W.L.Core & Associates, Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Drug-eluting stents
Prefilled syringes
Wearable injectors
Insulin injector drug
Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
Table of Contents
Executive Summary
1 Industry Overview of Drug Device Combination Products
- 1.1 Definition of Drug Device Combination Products
- 1.2 Drug Device Combination Products Segment by Type
- 1.2.1 Global Drug Device Combination Products Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Drug-eluting stents
- 1.2.3 Prefilled syringes
- 1.2.4 Wearable injectors
- 1.2.5 Insulin injector drug
- 1.3 Drug Device Combination Products Segment by Applications
- 1.3.1 Global Drug Device Combination Products Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals and Clinics
- 1.3.3 Medical Laboratories
- 1.3.4 Others
- 1.4 Global Drug Device Combination Products Overall Market
- 1.4.1 Global Drug Device Combination Products Revenue (2014-2025)
- 1.4.2 Global Drug Device Combination Products Production (2014-2025)
- 1.4.3 North America Drug Device Combination Products Status and Prospect (2014-2025)
- 1.4.4 Europe Drug Device Combination Products Status and Prospect (2014-2025)
- 1.4.5 China Drug Device Combination Products Status and Prospect (2014-2025)
- 1.4.6 Japan Drug Device Combination Products Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Drug Device Combination Products Status and Prospect (2014-2025)
- 1.4.8 India Drug Device Combination Products Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Drug Device Combination Products
- 2.3 Manufacturing Process Analysis of Drug Device Combination Products
- 2.4 Industry Chain Structure of Drug Device Combination Products
3 Development and Manufacturing Plants Analysis of Drug Device Combination Products
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Drug Device Combination Products Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Drug Device Combination Products
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Drug Device Combination Products Production and Capacity Analysis
- 4.2 Drug Device Combination Products Revenue Analysis
- 4.3 Drug Device Combination Products Price Analysis
- 4.4 Market Concentration Degree
5 Drug Device Combination Products Regional Market Analysis
- 5.1 Drug Device Combination Products Production by Regions
- 5.1.1 Global Drug Device Combination Products Production by Regions
- 5.1.2 Global Drug Device Combination Products Revenue by Regions
- 5.2 Drug Device Combination Products Consumption by Regions
- 5.3 North America Drug Device Combination Products Market Analysis
- 5.3.1 North America Drug Device Combination Products Production
- 5.3.2 North America Drug Device Combination Products Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Drug Device Combination Products Import and Export
- 5.4 Europe Drug Device Combination Products Market Analysis
- 5.4.1 Europe Drug Device Combination Products Production
- 5.4.2 Europe Drug Device Combination Products Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Drug Device Combination Products Import and Export
- 5.5 China Drug Device Combination Products Market Analysis
- 5.5.1 China Drug Device Combination Products Production
- 5.5.2 China Drug Device Combination Products Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Drug Device Combination Products Import and Export
- 5.6 Japan Drug Device Combination Products Market Analysis
- 5.6.1 Japan Drug Device Combination Products Production
- 5.6.2 Japan Drug Device Combination Products Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Drug Device Combination Products Import and Export
- 5.7 Southeast Asia Drug Device Combination Products Market Analysis
- 5.7.1 Southeast Asia Drug Device Combination Products Production
- 5.7.2 Southeast Asia Drug Device Combination Products Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Drug Device Combination Products Import and Export
- 5.8 India Drug Device Combination Products Market Analysis
- 5.8.1 India Drug Device Combination Products Production
- 5.8.2 India Drug Device Combination Products Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Drug Device Combination Products Import and Export
6 Drug Device Combination Products Segment Market Analysis (by Type)
- 6.1 Global Drug Device Combination Products Production by Type
- 6.2 Global Drug Device Combination Products Revenue by Type
- 6.3 Drug Device Combination Products Price by Type
7 Drug Device Combination Products Segment Market Analysis (by Application)
- 7.1 Global Drug Device Combination Products Consumption by Application
- 7.2 Global Drug Device Combination Products Consumption Market Share by Application (2014-2019)
8 Drug Device Combination Products Major Manufacturers Analysis
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Drug Device Combination Products Production Sites and Area Served
- 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.1.3 Abbott Laboratories Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Terumo Corporation
- 8.2.1 Terumo Corporation Drug Device Combination Products Production Sites and Area Served
- 8.2.2 Terumo Corporation Product Introduction, Application and Specification
- 8.2.3 Terumo Corporation Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Stryker Corporation
- 8.3.1 Stryker Corporation Drug Device Combination Products Production Sites and Area Served
- 8.3.2 Stryker Corporation Product Introduction, Application and Specification
- 8.3.3 Stryker Corporation Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Mylan N.V.
- 8.4.1 Mylan N.V. Drug Device Combination Products Production Sites and Area Served
- 8.4.2 Mylan N.V. Product Introduction, Application and Specification
- 8.4.3 Mylan N.V. Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Medtronic
- 8.5.1 Medtronic Drug Device Combination Products Production Sites and Area Served
- 8.5.2 Medtronic Product Introduction, Application and Specification
- 8.5.3 Medtronic Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 St.Jude Medical, Inc.
- 8.6.1 St.Jude Medical, Inc. Drug Device Combination Products Production Sites and Area Served
- 8.6.2 St.Jude Medical, Inc. Product Introduction, Application and Specification
- 8.6.3 St.Jude Medical, Inc. Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Allergan, Plc
- 8.7.1 Allergan, Plc Drug Device Combination Products Production Sites and Area Served
- 8.7.2 Allergan, Plc Product Introduction, Application and Specification
- 8.7.3 Allergan, Plc Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Boston Scientific Corporation
- 8.8.1 Boston Scientific Corporation Drug Device Combination Products Production Sites and Area Served
- 8.8.2 Boston Scientific Corporation Product Introduction, Application and Specification
- 8.8.3 Boston Scientific Corporation Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Novartis AG
- 8.9.1 Novartis AG Drug Device Combination Products Production Sites and Area Served
- 8.9.2 Novartis AG Product Introduction, Application and Specification
- 8.9.3 Novartis AG Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Teleflex Incorporated
- 8.10.1 Teleflex Incorporated Drug Device Combination Products Production Sites and Area Served
- 8.10.2 Teleflex Incorporated Product Introduction, Application and Specification
- 8.10.3 Teleflex Incorporated Drug Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 C.R. Bard, Inc.
- 8.12 W.L.Core & Associates, Inc.
9 Development Trend of Analysis of Drug Device Combination Products Market
- 9.1 Global Drug Device Combination Products Market Trend Analysis
- 9.1.1 Global Drug Device Combination Products Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Drug Device Combination Products Regional Market Trend
- 9.2.1 North America Drug Device Combination Products Forecast 2019-2025
- 9.2.2 Europe Drug Device Combination Products Forecast 2019-2025
- 9.2.3 China Drug Device Combination Products Forecast 2019-2025
- 9.2.4 Japan Drug Device Combination Products Forecast 2019-2025
- 9.2.5 Southeast Asia Drug Device Combination Products Forecast 2019-2025
- 9.2.6 India Drug Device Combination Products Forecast 2019-2025
- 9.3 Drug Device Combination Products Market Trend (Product Type)
- 9.4 Drug Device Combination Products Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Drug Device Combination Products Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Drug Device Combination Products. Industry analysis & Market Report on Drug Device Combination Products is a syndicated market report, published as Global Drug Device Combination Products Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Drug Device Combination Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
